Open access
Sep 2026
Immunotherapy with Pembrolizumab beyond Progression and Local Ablative Therapy in Oligoprogressive Metastatic Non-Small Cell Lung Cancer
In this retrospective analysis, treatment BPD was not associated with an improved prognosis compared to 2L therapy and there is a need to improve and implement criteria to select patients who truly benefit from this treatment approach.
A. Oseledchyk, L. Häcker, A. Schmitt et al.
· Oncology Research and Treatm... · 0 citations